What is the best treatment plan for a patient with refractory migraine who has already tried sumatriptan, topiramate, Norgesic (opioid‑containing preparation), ibuprofen, and ketorolac without success?

Refractory Migraine Management After Multiple Treatment Failures

For this patient with true refractory migraine who has failed sumatriptan, topiramate, NSAIDs (ibuprofen, ketorolac), and opioid-containing preparations (Norgesic), the next step is to initiate CGRP monoclonal antibodies (erenumab, fremanezumab, or galcanezumab) or onabotulinumtoxinA injections, depending on whether this represents chronic migraine (≥15 headache days/month). 1

Critical First Step: Rule Out Medication Overuse Headache (MOH)

Before proceeding with advanced therapies, you must determine if frequent use of sumatriptan, ketorolac, ibuprofen, or Norgesic (which contains opioids) has caused MOH. If the patient is using acute medications ≥10 days/month (for triptans/opioids) or ≥15 days/month (for NSAIDs), abrupt withdrawal of the overused medication is required first (except for opioids, which require tapering). 1 MOH frequently mimics chronic migraine and must be addressed before escalating preventive therapy.

Determine Migraine Classification

• If chronic migraine (≥15 headache days/month for >3 months): Evidence-based options are topiramate, onabotulinumtoxinA, or CGRP monoclonal antibodies 1
• If episodic migraine (<15 headache days/month): Consider alternative preventive medications before moving to injectables

Recommended Treatment Algorithm

For Chronic Migraine (Most Likely Given "Refractory" Description):

First-line after topiramate failure: Since topiramate has already failed, proceed directly to either:

1. OnabotulinumtoxinA injections - Proven effective for chronic migraine prevention 2, 1. This is typically more accessible due to lower cost compared to CGRP antibodies.

2. CGRP monoclonal antibodies (erenumab, fremanezumab, or galcanezumab) - These have demonstrated efficacy specifically in patients who failed 2-3 prior preventive medications 1. Regulatory restrictions often require documented failure of 2-3 preventive medications first, which this patient has met.

Acute Treatment Optimization:

While establishing preventive therapy, optimize acute treatment:

• Replace sumatriptan with alternative triptans: Try eletriptan, rizatriptan, or zolmitriptan, as individual response varies significantly between triptans 2, 3
• Combination therapy: Triptan + fast-acting NSAID (naproxen sodium) taken simultaneously to prevent recurrence 1
• Consider gepants (rimegepant or ubrogepant) as third-line acute therapy 2, 1 - these have lower risk of medication overuse headache compared to triptans
• Avoid continuing Norgesic (opioid-containing): Opioids should not be used routinely for migraine and increase risk of chronification 1, 4

Additional Preventive Options to Trial Before Injectables (If Not Chronic Migraine):

If this represents episodic migraine or if injectables are not accessible:

• Propranolol 2
• Valproate 2
• Lisinopril 2
• Memantine 2
• Atogepant (oral CGRP antagonist) 2
• Amitriptyline - particularly if comorbid depression or sleep disturbances exist 1

Assessment Timeline

• OnabotulinumtoxinA: Assess efficacy only after 2-3 treatment cycles (6-9 months) 1
• CGRP antibodies: Assess efficacy after 3-6 months 1
• Oral preventives: Trial for 2-3 months at therapeutic dose before declaring failure 1

Comorbidity Considerations

Evaluate and address:

• Depression/anxiety: Consider amitriptyline as preventive 1
• Obesity: Topiramate already tried; weight management critical as obesity increases chronification risk 1
• Sleep disturbances: May benefit from amitriptyline 1

Specialist Referral

This patient requires referral to headache specialist or neurology given the refractory nature and need for advanced therapies like onabotulinumtoxinA or CGRP antibodies. 1 Refractory migraine management is challenging and benefits from multidisciplinary approaches including behavioral interventions, biofeedback, and cognitive behavioral therapy alongside pharmacotherapy. 5, 6

Critical Pitfalls to Avoid

• Do not continue opioid-containing preparations (Norgesic) - these worsen outcomes and promote chronification 1, 4
• Do not add more oral preventives without addressing MOH first - this will fail 1
• Do not declare treatment failure prematurely - adequate trials require 2-3 months for oral agents, longer for injectables 1
• Do not use ketorolac routinely - while effective acutely 3, 7, frequent use risks MOH and renal/GI complications